ArticleSensors (Basel, Switzerland)2023
An Investigation about Modern Deep Learning Strategies for Colon Carcinoma Grading.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Hawthorn Proanthocyanidin Extract Inhibits Colorectal Carcinoma Metastasis by Targeting the Epithelial-Mesenchymal Transition Process and Wnt/β-Catenin Signaling Pathway.Foods (Basel, Switzerland) · 2024Article
- It Is What the Surgeon Does Not See That Kills the Patient.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Developing computer-aided approaches for cancer diagnosis and grading is currently receiving an increasing demand: this could take over intra- and inter-observer inconsistency, speed up the screening process, increase early diagnosis, and improve the accuracy and consistency of the treatment-planning processes.The third most common cancer worldwide and the second most common in women is colorectal cancer (CRC). Grading CRC is a key task in planning appropriate treatments and estimating the response to them. Unfortunately, it has not yet been fully demonstrated how the most advanced models and methodologies of machine learning can impact this crucial task.This paper systematically investigates the use of advanced deep models (convolutional neural networks and transformer architectures) to improve colon carcinoma detection and grading from histological images. To the best of our knowledge, this is the first attempt at using transformer architectures and ensemble strategies for exploiting deep learning paradigms for automatic colon cancer diagnosis. Results on the largest publicly available dataset demonstrated a substantial improvement with respect to the leading state-of-the-art methods. In particular, by exploiting a transformer architecture, it was possible to observe a 3% increase in accuracy in the detection task (two-class problem) and up to a 4% improvement in the grading task (three-class problem) by also integrating an ensemble strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.